Related Experiment Videos
Kawasaki Disease Recurrence as a Diagnostic and Therapeutic Challenge: A Case Report
Irma Martínez Tovar1,2, Lourdes E Escalante Madera2, Ana M Tiscareño Guzmán3
1Pediatrics, General Hospital Aguascalientes of the Institute of Security and Social Services of State Workers, Aguascalientes, MEX.
Insights
Recurrent Kawasaki disease (KD) can occur after initial treatment. This case highlights a child with recurrent KD who did not develop coronary artery issues following standard intravenous immunoglobulin therapy.
Area of Science:
- Pediatric Rheumatology
- Systemic Vasculitis
- Kawasaki Disease Etiology
Background:
- Kawasaki disease (KD) is a leading cause of acquired heart disease in children.
- While typically self-limiting, KD can lead to severe cardiovascular complications.
- Standard treatment involves intravenous immunoglobulin (IVIG) and aspirin (ASA).
Abstract:
Kawasaki disease (KD) is a systemic vasculitis typically affecting children. It is usually self-limited, lasting less than two weeks without treatment; however, cardiovascular complications can occur, causing significant morbidity and mortality. Diagnosis is generally clinical, and treatment follows standardized guidelines, primarily intravenous immunoglobulin (IVIG) combined with acetylsalicylic acid (ASA), with or without corticosteroids, depending on the severity. Among KD types, refractory disease is defined by persistent fever after initial therapy, and recurrent disease is defined by the presence of at least three of the five classic KD criteria occurring at least 14 days after returning to baseline health. This case reports an 11-month-old female patient with recurrent KD without coronary complications after appropriate initial IVIG treatment.